ArticleNature biotechnology2020

Peptide-TLR-7/8a conjugate vaccines chemically programmed for nanoparticle self-assembly enhance CD8 T-cell immunity to tumor antigens.

Geoffrey M Lynn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.